Log inSign up

Asklepios BioPharmaceutical

1 follower

‌

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Industries

Biotechnology, Health Care

Headquarters

Chapel Hill, United States

Employees

51-200

Links

Org chart

Gustavo Pesquin
CEO

Gustavo Pesquin

Collapse
R. Jude Samulski
President, Chief Scientific Officer & Co-Founder
Canwen Jiang
Chief Development Officer & CMO
Josh Grieger
CTO
Candace Summerford
Chief Patent Officer
Tracy Dowling
General Counsel & Head of Business Development
Mansuo L Shannon
Board Member
Melissa Murrell
Chief People Officer

Teams

+1

Leadership Team

4 members

+2

Business Development and Strategy

5 members

MY

Clinical Operations

3 members

Regulatory and Quality Assurance

3 members

Similar companies

SpringWorks Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Stemline Therapeutics

3 followers

Precigen

3 followers

Tenaya Therapeutics

2 followers

Arcutis Biotherapeutics

2 followers

FirstWord Group

2 followers

Merck

219 followers

Dragonfly Therapeutics

1 follower

Emulate

1 follower

Biosynth

1 follower

Explore companies